Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29251855 | 0.79 | CA1 (0.40) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| SCHEMBL8370925 | 0.79 | MEN1 (0.31) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL13538039 | 0.75 | LMNA (0.41) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| Acetic Acid SCHEMBL30330496 | 0.75 | CHRM2 (0.38) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| SCHEMBL17338057 | 0.74 | — | — | |
| SCHEMBL11204343 | 0.73 | TSHR (0.50) | TSHRCTDSP1HTT | |
| SCHEMBL575098 | 0.72 | CHRNA7 (0.34) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| SCHEMBL19307655 | 0.72 | CHRNA7 (0.34) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| SCHEMBL2865219 | 0.72 | CHRNA7 (0.34) | CHRM2CHRM4CHRM5CYP2D6CHRM1 | |
| SCHEMBL19307694 | 0.72 | CHRNA7 (0.34) | CHRM2CHRM4CHRM5CYP2D6CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2430195-B1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA INC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-20140065627-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-8519125-B2 | Compositions and methods for biological sample storage | BIOMATRICA, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| EP-2430195-A2 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | Biomatrica, INC. (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20110081363-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2011-04-07 | — | — | US | disclosed |
| WO-2010132508-A2 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | BIOMATRICA, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110081363-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL SAMPLE STORAGE | DNASE1, DIS3, NEFM | CHRM2 3816/4885CHRM4 4462/4885CHRM5 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.